Time limits apply in Florida. Find out if you still qualify.
Quick Eligibility Review
Answer one question at a time. This usually takes under 2 minutes.
Check your eligibility — free
Answer 2-3 quick questions to review your potential case.
Verified against court and regulatory records · No upfront fees · Your information is never sold
Statute of limitations — Florida
Florida Statute § 95.11(3)(a) provides a 2-year statute of limitations for personal injury claims including pharmaceutical product liability (reduced from 4 years by 2023 tort reform). The discovery rule applies — the clock starts when the plaintiff discovers or reasonably should have discovered Elmiron caused their vision damage. Florida has a 12-year statute of repose under § 95.031(2)(b).
2 years from discovery of Elmiron-related vision injury
Filing venue
Where to File in Florida
Federal Elmiron cases from Florida are transferred to the MDL in the District of New Jersey (MDL No. 2973). Florida state court claims may proceed separately in Miami-Dade, Broward, Hillsborough, or Palm Beach County circuit courts. Florida's 2023 tort reform shortened the statute of limitations from 4 to 2 years, which may catch some plaintiffs off guard. Florida courts apply the Daubert standard for expert testimony. The state's large elderly population and high IC diagnosis rates make it one of the top-filing states in the MDL.
Florida data
Exposure in Florida
Florida population — third-largest state with a disproportionately high rate of interstitial cystitis due to older demographics
22.6 million
Source: U.S. Census Bureau 2024
The specific retinal condition linked to Elmiron — characterized by dark spots on the macula that can cause blurred vision, difficulty reading, and adaptation problems in dim lighting
Pigmentary maculopathy
Source: American Academy of Ophthalmology
Year Elmiron was originally FDA-approved — patients took the drug for decades before the retinal toxicity link was identified by Emory University researchers in 2018
1996
Source: FDA drug approval records
Keep reading